JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
StreetZero Signal 58
About JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Founded in 2003 and headquartered in Dublin, Ireland, the company is publicly traded on NASDAQ under ticker JAZZ. It operates as a public company in the pharmaceutical manufacturing sector with a focus on biopharmaceutical medicines.
LATEST FUNDINGRule 144
$225K
Announced 2026-11-03
IN THE NEWS
- 🔗 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
- 🔗 Jazz Pharmaceuticals - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 Jazz Pharmaceuticals Denmark ApS - 2026 Company Profile - Tracxn
- 🔗 Jazz Pharmaceuticals, Inc. Announces Initial Public Offering | Jazz Pharmaceuticals plc
- 🔗 Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) Press Releases | Nasdaq
EMPLOYEES—
FOUNDED2003
HQDublin, Ireland
Industry
Public Equity (NASDAQ)
Tags
PharmaceuticalPublic CompanyBiopharmaNeurology
Key highlights
- Completed $225,370 Rule 144 placement as public company
- Went public via IPO on NASDAQ in 2007
- Focuses on innovative medicines for neurology and psychiatry
- Headquartered in Dublin with global operations
Ask StreetZero about JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account